Prof Jeremy Chataway
Prof Jeremy Chataway
Professor Chataway's research career is centred around clinical trials in neurology. The disease area he works in is dominantly (though not exclusively) multiple sclerosis (MS), and within that, the less tractable progressive stage. The clinical trials increasingly form a backbone around which a large number of experimental sub-studies, investigating pathogenic/mechanistic aspects of MS take place. Repurposing of agents is vital to facilitate translation of experimental work, and that is a particular interest.
He has a strong interest in advanced (such as multi-arm multi-stage[MAMS]) clinical trial design and is the Chief Investigator of the MS-STAT, MS-SMART and OCTOPUS trial programmes in Progressive MS. He is a Programme Lead for Neurodegeneration at the MRC Clinical Trial Unit.
A recent publication is: Clinical trials for progressive multiple sclerosis: progress, new lessons learned, and remaining challenges (Lancet Neurology March 2024)